Mounjaro: The first GIP & GLP-1 receptor agonist for T2D treatment

To explore the first and only GIP & GLP-1 receptor agonist for T2D management

Mounjaro: The first GIP & GLP-1 receptor agonist for T2D treatment English

Overview

To explore the first and only GIP & GLP-1 receptor agonist for T2D management

This Activity for

  • Resident / Fellow
  • Physician

What I will learn?

the first GIP & GLP-1 receptor agonist through an engaging discussion with investigators covering MoA, Phase III SURPASS trial program and appropriate patient.

Additional items to the activity

Optional Details Type Fee
Mounjaro: The first GIP & GLP-1 receptor agonist for T2D treatment Certificate

Certificate

Certificate Free
VAT 15% Included

About Organizer

Contact the organizer and they will be glad to help!

Virtual Medical Academy

Email: [email protected]
Phone: +966920008161

was 0 SAR

Free
0%coupon Discount
  • calendar 05 Jul 2023
  • clock 09:00 pm - 10:00 pm - Saudi Arabia (+03:00)
  • quality Certificate Available
  • adjust no access Materiel
  • Registration Policy Full Course
  • Completion Role You must attend all the Sessions
  • Refund Policy No Refund
Free